Retrospective Analysis of Long-term Impact of COVID-19 Pandemic on Mammographic Breast Cancer Screening
The COVID-19 pandemic was associated with sustained declines in MBCS through early 2023, disproportionately affecting vulnerable populations but did not widen pre-existing disparities, highlighting the benefits of targeted interventions.
Authors
- Dhauna Karam (ORCID: https://orcid.org/0000-0002-9420-7410)
- Joshua C. Pritchett (ORCID: https://orcid.org/0000-0001-6139-5526)
- Kathryn J. Ruddy (ORCID: https://orcid.org/0000-0001-6298-332X)
- Tufia C. Haddad (ORCID: https://orcid.org/0000-0001-8226-3581)
- Heidi Kosiorek (ORCID: https://orcid.org/0000-0002-4651-9516)
- Mohammed Yousufuddin (ORCID: https://orcid.org/0000-0002-7496-9856)
- Alyssa McGary
- Richard L. Ellis (ORCID: https://orcid.org/0000-0002-0918-0496)
Institutions
- Mayo Clinic Health System (US)
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- Mayo Clinic Proceedings Innovations Quality & Outcomes
- Published
- 2025-12-06
- DOI
- https://doi.org/10.1016/j.mayocpiqo.2025.100680
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00